| scholarly article | Q13442814 |
| P50 | author | Sharon L R Kardia | Q88218091 |
| Thomas Giordano | Q37621567 | ||
| P2093 | author name string | Lin Lin | |
| David E Misek | |||
| Samir Hanash | |||
| David G Beer | |||
| Guoan Chen | |||
| Albert M Levin | |||
| Dafydd G Thomas | |||
| Chiang-Ching Huang | |||
| Mark B Orringer | |||
| Satoru Hayasaka | |||
| Rork Kuick | |||
| Jeremy M G Taylor | |||
| Mark D Iannettoni | |||
| Michelle L Lizyness | |||
| Tarek G Gharib | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up | Q75270526 | ||
| A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation | Q24535521 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Diversity of gene expression in adenocarcinoma of the lung | Q29616070 | ||
| Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | Q29616071 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report | Q30583610 | ||
| Molecular profiling of human cancer | Q30659943 | ||
| Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. | Q33890759 | ||
| C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. | Q34124421 | ||
| Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases | Q34564259 | ||
| Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles | Q35746921 | ||
| Vascular endothelial growth factor and lymph node metastasis in primary lung cancer | Q36431274 | ||
| Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer | Q36642239 | ||
| IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells | Q38310512 | ||
| Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group | Q40221475 | ||
| Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications | Q41082338 | ||
| Expression of the glucocorticoid receptor and K-ras genes in urethan-induced mouse lung tumors and transformed cell lines | Q41691884 | ||
| Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene | Q41738933 | ||
| Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women | Q46963745 | ||
| Asymptotics for and against cross-validation | Q56019666 | ||
| Gene-Expression Profiles in Hereditary Breast Cancer | Q57240053 | ||
| Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 CM in diameter | Q68322610 | ||
| K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung | Q68532141 | ||
| Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung | Q70193311 | ||
| Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease | Q72395994 | ||
| Genome-wide views of cancer | Q73510089 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 816-824 | |
| P577 | publication date | 2002-07-15 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Gene-expression profiles predict survival of patients with lung adenocarcinoma | |
| P478 | volume | 8 |
| Q33362789 | "Omics" data and levels of evidence for biomarker discovery |
| Q33696276 | 17alpha-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response. |
| Q34227755 | A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer |
| Q34362351 | A Bayesian model for cross-study differential gene expression |
| Q34613191 | A Gaussian Mixed Model for Learning Discrete Bayesian Networks |
| Q51176917 | A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance. |
| Q92882068 | A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches |
| Q47590835 | A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma |
| Q36082941 | A Partitioning Based Adaptive Method for Robust Removal of Irrelevant Features from High-dimensional Biomedical Datasets |
| Q79165352 | A better crystal ball to predict lung-cancer survival? |
| Q90576746 | A clonal expression biomarker associates with lung cancer mortality |
| Q28276647 | A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis |
| Q35584849 | A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft. |
| Q31150616 | A comparative study of different machine learning methods on microarray gene expression data |
| Q47360183 | A comparison of oligonucleotide and cDNA-based microarray systems |
| Q34814723 | A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis |
| Q35017006 | A four-gene signature predicts disease progression in muscle invasive bladder cancer. |
| Q39845869 | A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival |
| Q35220047 | A gene expression signature associated with survival in metastatic melanoma |
| Q28764568 | A gene expression signature predicts survival of patients with stage I non-small cell lung cancer |
| Q24647664 | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene |
| Q34555834 | A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. |
| Q93128681 | A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies |
| Q35830723 | A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assay |
| Q33854958 | A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma |
| Q38624030 | A meta-analysis: microRNAs' prognostic function in patients with nonsmall cell lung cancer. |
| Q38013066 | A methodological approach to unravel organ-specific breast cancer metastasis. |
| Q36354915 | A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. |
| Q36344539 | A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy |
| Q27303204 | A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival |
| Q58084975 | A multi-gene expression profile panel for predicting liver metastasis: An algorithmic approach |
| Q28247365 | A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma |
| Q42921192 | A new validity measure for a correlation-based fuzzy c-means clustering algorithm |
| Q64107493 | A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis |
| Q28387995 | A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC |
| Q37725502 | A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors |
| Q88657584 | A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients |
| Q34478770 | A pilot characterization of human lung NSCLC by protein pathway activation mapping |
| Q35803022 | A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies |
| Q41959377 | A prognostic model for the combined analysis of gene expression profiling in hepatocellular carcinoma |
| Q37143757 | A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients |
| Q23918749 | A smoking-associated 7-gene signature for lung cancer diagnosis and prognosis |
| Q85074930 | A supervised approach for predicting patient survival with gene expression data |
| Q39310594 | A systems biological approach to identify key transcription factors and their genomic neighborhoods in human sarcomas |
| Q36004656 | A systems biology approach for pathway level analysis |
| Q36519704 | A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to bone |
| Q34109267 | A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas |
| Q64941546 | A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma. |
| Q35484686 | APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis |
| Q35073828 | ATHENA: Identifying interactions between different levels of genomic data associated with cancer clinical outcomes using grammatical evolution neural network |
| Q21092374 | Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer |
| Q42238571 | Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing |
| Q36843220 | Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling |
| Q30444847 | Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. |
| Q33800021 | Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6. |
| Q36097503 | Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer |
| Q36973076 | Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics |
| Q31008766 | Advances in proteomic strategies toward the early detection of lung cancer |
| Q35551113 | Advantages and limitations of microarray technology in human cancer |
| Q39246681 | All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses |
| Q34586258 | Alterations in gene expression of proprotein convertases in human lung cancer have a limited number of scenarios. |
| Q92541735 | An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma |
| Q42776111 | An Integrative Pathway-based Clinical-genomic Model for Cancer Survival Prediction |
| Q81761383 | An array of problems |
| Q31160337 | An efficient concordant integrative analysis of multiple large-scale two-sample expression data sets |
| Q42160908 | An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma |
| Q33393471 | An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer |
| Q36002695 | An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation. |
| Q31026297 | An integrated strategy for the optimization of microarray data interpretation. |
| Q47608135 | An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis |
| Q36731621 | Analysis of microarray experiments of gene expression profiling. |
| Q35094438 | Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model |
| Q73739175 | Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients |
| Q30946829 | Application of Bayesian logistic regression to mining biomedical data |
| Q35043479 | Application of DNA microarrays in pharmacogenomics and toxicogenomics |
| Q37728675 | Application of RT-PCR in formalin-fixed and paraffin-embedded lung cancer tissues |
| Q33974282 | Application of an efficient Bayesian discretization method to biomedical data |
| Q35120292 | Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice. |
| Q34593019 | Assessment of reproducibility of cancer survival risk predictions across medical centers |
| Q33908320 | Association rule based similarity measures for the clustering of gene expression data |
| Q36361117 | Automated multigroup outlier identification in molecular high-throughput data using bagplots and gemplots |
| Q39656321 | BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients |
| Q33414654 | BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource |
| Q28387249 | BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion |
| Q34224547 | Bayesian method to predict individual SNP genotypes from gene expression data |
| Q35632505 | Bayesian profiling of molecular signatures to predict event times |
| Q33524687 | Bayesian rule learning for biomedical data mining |
| Q47101079 | Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer |
| Q39695768 | Big results from small samples: evaluation of amplification protocols for gene expression profiling. |
| Q54959928 | Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer. |
| Q34433946 | Biological impact of missing-value imputation on downstream analyses of gene expression profiles |
| Q38844239 | Biomarker development in the precision medicine era: lung cancer as a case study. |
| Q40358308 | Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. |
| Q38997362 | Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells |
| Q47633149 | Building Diversified Multiple Trees for classification in high dimensional noisy biomedical data. |
| Q93111200 | CFHR1 is a potentially downregulated gene in lung adenocarcinoma |
| Q34023291 | CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer |
| Q93054558 | CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer |
| Q33562564 | CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes. |
| Q39386469 | CYP24 inhibition preserves 1α,25-dihydroxyvitamin D(3) anti-proliferative signaling in lung cancer cells. |
| Q34680398 | CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma |
| Q37938716 | Calcium-binding protein S100P and cancer: mechanisms and clinical relevance |
| Q24801522 | Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung? |
| Q34301489 | Cancer core modules identification through genomic and transcriptomic changes correlation detection at network level |
| Q34962407 | Cancer gene discovery in mouse and man. |
| Q35942318 | Cancer survival analysis using semi-supervised learning method based on Cox and AFT models with L1/2 regularization |
| Q37204620 | Candida albicans triggers the expression of inflammatory genes in human umbilical vein endothelial cells |
| Q28508198 | Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability |
| Q45233639 | Challenges translating breast cancer gene signatures into the clinic |
| Q35016759 | Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma |
| Q37146877 | Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer |
| Q23916995 | Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains |
| Q59401466 | Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression |
| Q52087746 | Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. |
| Q94552626 | Clinical and prognostic significance of MYH11 in lung cancer |
| Q37317171 | Clinical impact of high-throughput gene expression studies in lung cancer |
| Q51018353 | Clinical utility of KAP-1 expression in thyroid lesions. |
| Q38836749 | Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer |
| Q33641395 | Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study |
| Q34530234 | Cliques for the identification of gene signatures for colorectal cancer across population |
| Q54680535 | Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity. |
| Q51022866 | Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma. |
| Q64055175 | Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks |
| Q28386520 | Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based study |
| Q36519015 | Comparative and integrative functional genomics of HCC. |
| Q34324662 | Comparative evaluation of set-level techniques in predictive classification of gene expression samples |
| Q34075588 | Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma |
| Q35863265 | Comparison of RNA-seq and microarray-based models for clinical endpoint prediction |
| Q33634644 | Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR. |
| Q89463183 | Comprehensive analysis of inhibitor of differentiation/DNA-binding gene family in lung cancer using bioinformatics methods |
| Q91785632 | Comprehensive genomic and prognostic analysis of the IL‑17 family genes in lung cancer |
| Q35955982 | Comprehensive literature review and statistical considerations for microarray meta-analysis |
| Q28244995 | Comprehensive molecular profiling of lung adenocarcinoma |
| Q42057291 | Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction |
| Q30763267 | Concordant integrative gene set enrichment analysis of multiple large-scale two-sample expression data sets |
| Q23918759 | Confirmation of gene expression-based prediction of survival in non-small cell lung cancer |
| Q37619692 | Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma |
| Q24794295 | Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays |
| Q23916642 | Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma |
| Q99406606 | Contribution of annexin A1 to anticancer immunosurveillance |
| Q28243455 | Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment |
| Q33760596 | Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma |
| Q94101539 | Current Awareness on Comparative and Functional Genomics |
| Q35188471 | Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines. |
| Q30428813 | Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy |
| Q34014045 | Cytokines and their relationship to the symptoms and outcome of cancer. |
| Q52595632 | DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis. |
| Q35995077 | DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer |
| Q33448545 | Data mining for gene networks relevant to poor prognosis in lung cancer via backward-chaining rule induction |
| Q28762550 | Decentralized data sharing of tissue microarrays for investigative research in oncology |
| Q35793089 | Deconvolving heterogeneity in the CD8+ T-cell response to HIV. |
| Q35971891 | Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations |
| Q38348098 | DeltaNp73 can modulate the expression of various genes in a p53-independent fashion |
| Q34252449 | Detecting phenotype-specific interactions between biological processes from microarray data and annotations |
| Q55107289 | Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis. |
| Q38688789 | Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer |
| Q34412292 | Development and validation of a prognostic gene-expression signature for lung adenocarcinoma |
| Q35197454 | Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis. |
| Q33889725 | Development and validation of predictive indices for a continuous outcome using gene expression profiles. |
| Q39319196 | Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma. |
| Q36734636 | Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer |
| Q60915367 | Development of a miRNA-seq based prognostic signature in lung adenocarcinoma |
| Q38837312 | Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma |
| Q33594999 | Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer |
| Q50772691 | Diagnosis of Brain Metastases from Lung Cancer Using a Modified Electromagnetism like Mechanism Algorithm. |
| Q34562455 | Diagnostic molecular pathology: current techniques and clinical applications, part I. |
| Q36142630 | Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene-induced lung tumorigenesis in A/J mice |
| Q24815497 | Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors |
| Q35441165 | Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma |
| Q36373039 | Differential diagnosis of solitary lung nodules with gene expression ratios |
| Q35954280 | Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. |
| Q55350987 | Differential expression patterns of housekeeping genes increase diagnostic and prognostic value in lung cancer. |
| Q28730029 | Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation |
| Q38048501 | Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations |
| Q47906539 | Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer |
| Q55096489 | Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes. |
| Q33518813 | Dimension reduction of microarray gene expression data: the accelerated failure time model |
| Q33519717 | Discovering collectively informative descriptors from high-throughput experiments |
| Q36342774 | Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment |
| Q33682231 | Disease biomarker identification from gene network modules for metastasized breast cancer |
| Q30845649 | Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis |
| Q92358669 | Distinct Roles of VEGFA and ANGPT2 in Lung Adenocarcinoma and Squamous Cell Carcinoma |
| Q28273187 | Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome |
| Q35748986 | Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis |
| Q35768271 | Distinguishing lung tumours from normal lung based on a small set of genes |
| Q41354232 | Down-regulation of LAPTM5 in human cancer cells |
| Q34972375 | Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma |
| Q35774871 | Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients |
| Q42511544 | Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion |
| Q37688076 | Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis |
| Q35101874 | Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach |
| Q35828438 | ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion |
| Q34460151 | EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors |
| Q33827677 | Early response index: a statistic to discover potential early stage disease biomarkers. |
| Q35702968 | Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models |
| Q35971573 | Effects of cigarette smoke on the human airway epithelial cell transcriptome |
| Q37055963 | Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma. |
| Q34298569 | EnrichNet: network-based gene set enrichment analysis. |
| Q39663655 | Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules |
| Q34018681 | Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer |
| Q37714772 | Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma |
| Q36632214 | Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. |
| Q38723380 | Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. |
| Q36073367 | Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. |
| Q30536424 | Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies |
| Q34490042 | Exploring gene expression signatures for predicting disease free survival after resection of colorectal cancer liver metastases |
| Q35166399 | Expression and Distribution of Calcium-Binding Protein S100P in Human Placenta during Pregnancy |
| Q41702549 | Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers |
| Q42672586 | Expression levels of some antioxidant and epidermal growth factor receptor genes in patients with early-stage non-small cell lung cancer. |
| Q38984225 | Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer. |
| Q24337345 | Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer |
| Q55140498 | Expression of TARBP1 protein in human non-small-cell lung cancer and its prognostic significance. |
| Q40174892 | Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. |
| Q36680236 | Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance |
| Q80587761 | Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma |
| Q24814603 | Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension |
| Q36284742 | FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer |
| Q33418596 | Factors influencing the statistical power of complex data analysis protocols for molecular signature development from microarray data |
| Q24791649 | Feature extraction and signal processing for nylon DNA microarrays |
| Q35756955 | Feature selection and molecular classification of cancer using genetic programming |
| Q38642866 | Feature selection through validation and un-censoring of endovascular repair survival data for predicting the risk of re-intervention. |
| Q36141647 | From signatures to models: understanding cancer using microarrays |
| Q33604172 | Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer |
| Q39420364 | Functional networks inference from rule-based machine learning models. |
| Q24645628 | GAGE: generally applicable gene set enrichment for pathway analysis |
| Q31156851 | GEPAS, a web-based tool for microarray data analysis and interpretation |
| Q24813561 | GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data |
| Q41786499 | GPC5 gene and its related pathways in lung cancer |
| Q59265273 | Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer |
| Q33611881 | Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC. |
| Q26825706 | Gene expression analysis in RA: towards personalized medicine |
| Q34358385 | Gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancer |
| Q35843266 | Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans |
| Q44394270 | Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas |
| Q33805831 | Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients |
| Q35067591 | Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. |
| Q42127282 | Gene expression profiles from needle biopsies provide useful signatures of non-small cell lung carcinomas |
| Q33536148 | Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study |
| Q35589239 | Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses |
| Q36493959 | Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? |
| Q35554359 | Gene expression profiling identifies clinically relevant subtypes of prostate cancer |
| Q35228753 | Gene expression profiling in human lung development: an abundant resource for lung adenocarcinoma prognosis. |
| Q53370638 | Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. |
| Q35176444 | Gene expression profiling of endocrine tumors using DNA microarrays: progress and promise |
| Q36839018 | Gene expression profiling of non-small cell lung cancer |
| Q36613726 | Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. |
| Q38314691 | Gene expression profiling of target genes in ventilator-induced lung injury |
| Q35962933 | Gene expression studies in lung development and lung stem cell biology |
| Q28395058 | Gene expression-based classification of non-small cell lung carcinomas and survival prediction |
| Q33988433 | Gene expression-based prognostic signatures in lung cancer: ready for clinical use? |
| Q34798314 | Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study |
| Q40519649 | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients |
| Q30819413 | Gene selection for survival data under dependent censoring: A copula-based approach |
| Q24536351 | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles |
| Q34146519 | Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients |
| Q47130427 | Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection |
| Q29547479 | Genes that mediate breast cancer metastasis to lung |
| Q24798750 | Genetic alteration and gene expression modulation during cancer progression |
| Q38997311 | Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC. |
| Q30916881 | Genetic programming based ensemble system for microarray data classification |
| Q37628134 | Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients |
| Q30440216 | Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics. |
| Q36093867 | Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. |
| Q51121654 | Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis. |
| Q34104493 | Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors |
| Q35985492 | Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy |
| Q30482715 | Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features |
| Q102320151 | Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma |
| Q37500885 | Genomic profiling of liver cancer |
| Q36718611 | Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies |
| Q36303896 | Genomics in breast cancer-therapeutic implications |
| Q36084693 | Genomics of lung cancer may change diagnosis, prognosis and therapy |
| Q37171910 | Genomics of lung cancer. |
| Q37122824 | Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours |
| Q43441798 | Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma |
| Q34276961 | Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes |
| Q60046635 | GradientScanSurv-An exhaustive association test method for gene expression data with censored survival outcome |
| Q33369696 | Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. |
| Q28388539 | Growth of lung cancer cells in three-dimensional microenvironments reveals key features of tumor malignancy |
| Q36619063 | Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells |
| Q38646090 | HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology. |
| Q64090258 | HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma |
| Q64070066 | HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients |
| Q42263043 | HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner |
| Q81358751 | Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway |
| Q61797777 | High Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients |
| Q37080748 | High Expression of PTGR1 Promotes NSCLC Cell Growth via Positive Regulation of Cyclin-Dependent Protein Kinase Complex |
| Q36057106 | High expression of S100P is associated with unfavorable prognosis and tumor progression in patients with epithelial ovarian cancer |
| Q31075558 | High-dimensional genomic data bias correction and data integration using MANCIE |
| Q33966440 | High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. |
| Q36288148 | High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications |
| Q30479894 | High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry |
| Q51753083 | Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. |
| Q28396184 | Highlight report: Validation of prognostic genes in lung cancer |
| Q34205291 | Histology image analysis for carcinoma detection and grading |
| Q88139964 | How does genome sequencing impact surgery? |
| Q37135626 | Human lung project: evaluating variance of gene expression in the human lung |
| Q23924046 | Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction |
| Q64121066 | I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms |
| Q92533720 | IRF1 Negatively Regulates Oncogenic KPNA2 Expression Under Growth Stimulation and Hypoxia in Lung Cancer Cells |
| Q35601192 | ISOpureR: an R implementation of a computational purification algorithm of mixed tumour profiles. |
| Q36836098 | Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors |
| Q38454951 | Identification of certain cancer-mediating genes using Gaussian fuzzy cluster validity index |
| Q36630265 | Identification of common tumor signatures based on gene set enrichment analysis. |
| Q89495672 | Identification of differentially expressed protein-coding genes in lung adenocarcinomas |
| Q24791397 | Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data |
| Q39730118 | Identification of hypermethylated genes associated with cisplatin resistance in human cancers |
| Q33384993 | Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens |
| Q93173548 | Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples |
| Q46195024 | Identification of lung adenocarcinoma specific dysregulated genes with diagnostic and prognostic value across 27 TCGA cancer types |
| Q36047432 | Identification of metastasis-suppressive microRNAs in primary melanoma |
| Q34372539 | Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer. |
| Q47143254 | Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis |
| Q91755842 | Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma |
| Q37596249 | Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer. |
| Q35256884 | Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinoma. |
| Q88765096 | Identification of relevant subtypes via preweighted sparse clustering |
| Q35076226 | Identification of reproducible gene expression signatures in lung adenocarcinoma. |
| Q30697080 | Identification of significant features in DNA microarray data |
| Q43775179 | Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis. |
| Q37087309 | Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues. |
| Q34485698 | Identifying stage-specific protein subnetworks for colorectal cancer |
| Q33645624 | Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer |
| Q37438558 | Impact and interactions between smoking and traditional prognostic factors in lung cancer progression. |
| Q36539946 | Impact of collection and storage of lung tumor tissue on whole genome expression profiling |
| Q36856839 | Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma |
| Q36357410 | Improving the Prediction of Survival in Cancer Patients by Using Machine Learning Techniques: Experience of Gene Expression Data: A Narrative Review |
| Q36386730 | In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. |
| Q35325715 | In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery. |
| Q35870444 | Inactivation of LLC1 gene in nonsmall cell lung cancer |
| Q44582765 | Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas |
| Q39707915 | Increased cell migration and plasticity in Nrf2-deficient cancer cell lines |
| Q40551993 | Increased measurement accuracy for sequence-verified microarray probes |
| Q36117179 | Independent and functional validation of a multi-tumour-type proliferation signature |
| Q33403405 | Independent component analysis of Alzheimer's DNA microarray gene expression data |
| Q37579648 | Individualized therapy in non-small-cell lung cancer: future versus current clinical practice |
| Q34110415 | Inferring cancer subnetwork markers using density-constrained biclustering |
| Q33383213 | Inferring pathway activity toward precise disease classification |
| Q34032945 | Informative gene selection and direct classification of tumor based on Chi-square test of pairwise gene interactions |
| Q35899607 | Informative gene selection and the direct classification of tumors based on relative simplicity |
| Q35811338 | Injury research in the genomic era. |
| Q28397049 | Integrated DNA Copy Number and Gene Expression Regulatory Network Analysis of Non-small Cell Lung Cancer Metastasis |
| Q41936862 | Integrated expression profiles of mRNA and microRNA in the liver of Fructus Meliae Toosendan water extract injured mice |
| Q80402791 | Integrated global profiling of cancer |
| Q45943258 | Integrating Clinical and Multiple Omics Data for Prognostic Assessment across Human Cancers. |
| Q40629175 | Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. |
| Q35416193 | Integrating biological knowledge with gene expression profiles for survival prediction of cancer |
| Q35561695 | Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer |
| Q64111055 | Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma |
| Q28271520 | Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target |
| Q35751889 | Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy |
| Q24815430 | Integrative analysis of multiple gene expression profiles with quality-adjusted effect size models |
| Q30854282 | Integrative clustering methods for high-dimensional molecular data |
| Q37301705 | Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma. |
| Q92683700 | Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis |
| Q28284358 | Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma |
| Q28303718 | International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma |
| Q35106575 | Intestinal epithelial cells in vitro. |
| Q58053534 | Intrinsic cancer subtypes-next steps into personalized medicine |
| Q33801632 | Investigating the effect of paralogs on microarray gene-set analysis |
| Q36925740 | Investigating the efficacy of nonlinear dimensionality reduction schemes in classifying gene and protein expression studies |
| Q37311346 | Ion channels expression and function are strongly modified in solid tumors and vascular malformations |
| Q33412905 | Iterative Bayesian Model Averaging: a method for the application of survival analysis to high-dimensional microarray data |
| Q38328486 | Johne's disease in cattle is associated with enhanced expression of genes encoding IL-5, GATA-3, tissue inhibitors of matrix metalloproteinases 1 and 2, and factors promoting apoptosis in peripheral blood mononuclear cells. |
| Q24792469 | Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes |
| Q37886421 | KAP1 protein: an enigmatic master regulator of the genome |
| Q33394385 | KEGG spider: interpretation of genomics data in the context of the global gene metabolic network |
| Q54506769 | KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations. |
| Q28473103 | KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading |
| Q33366123 | Key issues in conducting a meta-analysis of gene expression microarray datasets |
| Q39603767 | Knockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells |
| Q42739835 | Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene |
| Q31120275 | Large-scale integration of cancer microarray data identifies a robust common cancer signature |
| Q89481519 | Laser-emission imaging of nuclear biomarkers for high-contrast cancer screening and immunodiagnosis |
| Q36319173 | Learning Parsimonious Classification Rules from Gene Expression Data Using Bayesian Networks with Local Structure |
| Q33743432 | Learning rule sets from survival data. |
| Q83181233 | Likelihood estimation of conjugacy relationships in linear models with applications to high-throughput genomics |
| Q36890028 | Local sparse bump hunting reveals molecular heterogeneity of colon tumors |
| Q33891486 | Loss of aquaporin-4 expression and putative function in non-small cell lung cancer |
| Q51485457 | Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase. |
| Q36833446 | Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome |
| Q28387769 | Lung Cancer Gene Signatures and Clinical Perspectives |
| Q47127472 | Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification |
| Q90639806 | Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells |
| Q37283058 | Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. |
| Q37285790 | Lung cancer gene expression database analysis incorporating prior knowledge with support vector machine-based classification method |
| Q37708137 | Lung cancer progression and metastasis from the prognostic point of view. |
| Q39741320 | Lung cancers unrelated to smoking: characterized by single oncogene addiction? |
| Q35183870 | Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma |
| Q38839830 | MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy |
| Q35004287 | MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples |
| Q33574955 | MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients |
| Q24798742 | Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery |
| Q35678516 | Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma |
| Q35719918 | Metagene projection for cross-platform, cross-species characterization of global transcriptional states |
| Q35055017 | Metagenes associated with survival in non-small cell lung cancer |
| Q39027918 | Metastatic signature in lung cancer is associated with sensitivity to anti-integrin α(V) monoclonal antibody intetumumab |
| Q39321613 | MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells |
| Q88122827 | MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2 |
| Q34256044 | MicroRNA in lung cancer |
| Q37297730 | MicroRNAs in the pathogenesis of Lung Cancer |
| Q24528253 | Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer |
| Q35123839 | Microarray analysis in the clinical management of cancer |
| Q33320174 | Microarray based diagnosis profits from better documentation of gene expression signatures |
| Q45090588 | Microarray reality checks in the context of a complex disease |
| Q36698823 | Microarray-based analysis of ventilator-induced lung injury |
| Q34776090 | Mining CK2 in cancer |
| Q36868498 | Mining gene expression profiles: expression signatures as cancer phenotypes |
| Q40536851 | Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis |
| Q93188487 | Modifications of disulfide bonds in breast cancer cell migration and invasiveness |
| Q33663130 | Module-based prediction approach for robust inter-study predictions in microarray data |
| Q35575040 | Molecular Fingerprinting in Human Lung Cancer |
| Q37653893 | Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. |
| Q37068774 | Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling |
| Q38107464 | Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis |
| Q37588387 | Molecular gene signature and prognosis of non-small cell lung cancer |
| Q35113786 | Molecular markers and staging of early esophageal cancer |
| Q33426873 | Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). |
| Q35010198 | Molecular portraits and the family tree of cancer |
| Q61773574 | Molecular profiles and clinical outcome of stage UICC II colon cancer patients |
| Q46071206 | Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma |
| Q57799336 | Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma |
| Q44582343 | Molecular signatures of lung cancer: defining new diagnostic and therapeutic paradigms |
| Q33518944 | Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer |
| Q30763386 | Multi-task feature selection in microarray data by binary integer programming |
| Q38729849 | Multiclass cancer classification based on gene expression comparison |
| Q37691784 | Multiplatform-based molecular subtypes of non-small-cell lung cancer |
| Q33378995 | Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival |
| Q33912866 | Multiple testing for gene sets from microarray experiments |
| Q40048458 | Mycoplasma and cancer: in search of the link |
| Q40198629 | NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas |
| Q49257510 | Network analysis of DEGs and verification experiments reveal the notable roles of PTTG1 and MMP9 in lung cancer. |
| Q30820140 | Network completion for static gene expression data |
| Q35599116 | Network-Based Identification of Smoking-Associated Gene Signature for Lung Cancer |
| Q38261249 | Network-based Pathway Enrichment Analysis |
| Q28469240 | Network-based analysis of affected biological processes in type 2 diabetes models |
| Q36677842 | Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patients |
| Q24796756 | Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect |
| Q33925945 | Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis. |
| Q30939961 | New challenges in gene expression data analysis and the extended GEPAS |
| Q31116667 | New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures |
| Q24680988 | New molecularly targeted therapies for lung cancer |
| Q37279547 | Novel Biomarker Candidates for Colorectal Cancer Metastasis: A Meta-analysis of In Vitro Studies |
| Q24339607 | Novel activity of KRAB domain that functions to reinforce nuclear localization of KRAB-containing zinc finger proteins by interacting with KAP1 |
| Q41691430 | Novel harmonic regularization approach for variable selection in Cox's proportional hazards model |
| Q28385611 | Novel image markers for non-small cell lung cancer classification and survival prediction |
| Q28744237 | Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer |
| Q28255103 | ONCOMINE: a cancer microarray database and integrated data-mining platform |
| Q96303706 | OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer |
| Q38813546 | Omics Profiling in Precision Oncology |
| Q30805789 | On integrating multi-experiment microarray data |
| Q28393146 | Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer |
| Q92450279 | Optimization and expansion of non-negative matrix factorization |
| Q34096074 | Optimized application of penalized regression methods to diverse genomic data |
| Q44624198 | Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma |
| Q54541339 | Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. |
| Q39344747 | Overlapping Group Logistic Regression with Applications to Genetic Pathway Selection. |
| Q57288705 | Overlapping clustering of gene expression data using penalized weighted normalized cut |
| Q33767514 | PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer |
| Q35176162 | PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma |
| Q50086993 | Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages. |
| Q36233709 | Pathogenesis of lung cancer: 100 year report |
| Q44269868 | Pathway Enrichment Analysis with Networks |
| Q42161246 | Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival |
| Q36974742 | Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway |
| Q33520625 | Penalized mixtures of factor analyzers with application to clustering high-dimensional microarray data |
| Q37778667 | Personalized Medicine: Marking a New Epoch in Cancer Patient Management |
| Q39019006 | Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model |
| Q30366103 | Personalized identification of altered pathways in cancer using accumulated normal tissue data. |
| Q80559048 | Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status |
| Q33933774 | Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas |
| Q33983713 | Photoinitiator nucleotide for quantifying nucleic Acid hybridization. |
| Q31171461 | Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens |
| Q37677039 | Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery |
| Q35757521 | Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. |
| Q33584831 | Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients |
| Q28741720 | Post-genomic clinical trials: the perspective of ACGT |
| Q73354973 | Potts Ferromagnets on Coexpressed Gene Networks: Identifying Maximally Stable Partitions |
| Q37209222 | Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions |
| Q37188409 | Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features |
| Q47322162 | Predicting phenotypes from microarrays using amplified, initially marginal, eigenvector regression |
| Q33237070 | Predicting survival outcomes using subsets of significant genes in prognostic marker studies with microarrays |
| Q33247966 | Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development |
| Q62785637 | Prediction of cancer outcome with microarrays: a multiple random validation strategy |
| Q34162893 | Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma |
| Q36976971 | Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimens |
| Q42970522 | Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. |
| Q30500051 | Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model |
| Q45116933 | Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). |
| Q33650639 | Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer |
| Q98177999 | Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling |
| Q33239651 | Profiling alternatively spliced mRNA isoforms for prostate cancer classification |
| Q35089389 | Profiling cancer |
| Q24796587 | Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice |
| Q33434943 | PrognoScan: a new database for meta-analysis of the prognostic value of genes |
| Q64092944 | Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma |
| Q43026297 | Prognostic and predictive biomarkers post curative intent therapy |
| Q30497419 | Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer |
| Q47243110 | Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines |
| Q35548353 | Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia |
| Q33697964 | Prognostic factors in resected lung carcinomas |
| Q42176304 | Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative |
| Q30485836 | Prognostic gene signatures for non-small-cell lung cancer |
| Q30499935 | Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer |
| Q57159515 | Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomes |
| Q92696902 | Prognostic significance and biological function of Lamina-associated polypeptide 2 in non-small-cell lung cancer |
| Q90216681 | Prognostic significance of minichromosome maintenance mRNA expression in human lung adenocarcinoma |
| Q51779277 | Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. |
| Q51174218 | Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor. |
| Q33430210 | Prostate cancer-associated gene expression alterations determined from needle biopsies |
| Q34318367 | Protein Disulfide Isomerase Superfamily in Disease and the Regulation of Apoptosis |
| Q37089504 | Protein profiles associated with survival in lung adenocarcinoma |
| Q33785608 | Protein signature for non-small cell lung cancer prognosis |
| Q37709355 | Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor |
| Q31154301 | Proteomic patterns of tumour subsets in non-small-cell lung cancer |
| Q35057057 | Proteomics in translational cancer research: toward an integrated approach |
| Q30477329 | Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy |
| Q55246896 | RAN/RANBP2 polymorphisms and neuroblastoma risk in Chinese children: a three-center case-control study. |
| Q35683647 | RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally |
| Q39982575 | Ratio adjustment and calibration scheme for gene-wise normalization to enhance microarray inter-study prediction |
| Q38915283 | Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters. |
| Q36184659 | Recursive feature selection with significant variables of support vectors |
| Q24309409 | Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins |
| Q34296059 | Relation between smoking history and gene expression profiles in lung adenocarcinomas |
| Q35166782 | Renal cell carcinoma and the use of sorafenib |
| Q34982782 | Renal gene and protein expression signatures for prediction of kidney disease progression |
| Q28131820 | Repeated observation of breast tumor subtypes in independent gene expression data sets |
| Q33960941 | Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes. |
| Q24803008 | Reproducibility of oligonucleotide arrays using small samples |
| Q24648999 | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha |
| Q34308389 | Revisiting global gene expression analysis |
| Q30444490 | RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation |
| Q99629429 | Robust Variable and Interaction Selection for Logistic Regression and General Index Models |
| Q41885616 | Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes |
| Q42130407 | Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types |
| Q52566507 | Robust sparse accelerated failure time model for survival analysis. |
| Q36414207 | Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer |
| Q33685170 | S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer |
| Q38686041 | S100P is associated with proliferation and migration in nasopharyngeal carcinoma |
| Q37053083 | S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer |
| Q98386389 | SMAD-6, -7 and -9 are potential molecular biomarkers for the prognosis in human lung cancer |
| Q47739121 | SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation |
| Q35175659 | SPARCoC: a new framework for molecular pattern discovery and cancer gene identification |
| Q30597109 | Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes |
| Q37162810 | Sample size requirements for training high-dimensional risk predictors |
| Q35594477 | Schizophrenia detection and classification by advanced analysis of EEG recordings using a single electrode approach. |
| Q33254835 | Selecting normalization genes for small diagnostic microarrays |
| Q31114297 | Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme |
| Q35098956 | Selective model averaging with bayesian rule learning for predictive biomedicine |
| Q35543589 | Semi-supervised adaptive-height snipping of the hierarchical clustering tree |
| Q24804682 | Semi-supervised methods to predict patient survival from gene expression data |
| Q34180853 | Semi-supervised recursively partitioned mixture models for identifying cancer subtypes |
| Q99208455 | Set-based genetic association and interaction tests for survival outcomes based on weighted V statistics |
| Q35529736 | Signal Peptidase Complex Subunit 1 and Hydroxyacyl-CoA Dehydrogenase Beta Subunit Are Suitable Reference Genes in Human Lungs |
| Q35742690 | Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma |
| Q51557016 | Signaling protein signature predicts clinical outcome of non-small-cell lung cancer. |
| Q41735339 | Simple decision rules for classifying human cancers from gene expression profiles |
| Q35863199 | Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells |
| Q37328450 | Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition |
| Q33489546 | SlimPLS: a method for feature selection in gene expression-based disease classification |
| Q54090667 | Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells. |
| Q37287242 | Smoking-related genomic signatures in non-small cell lung cancer |
| Q33976991 | Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma |
| Q34928807 | Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection |
| Q30584008 | Statistical aspects of omics data analysis using the random compound covariate |
| Q37284250 | Statistical challenges in preprocessing in microarray experiments in cancer |
| Q27023018 | Statistical considerations for analysis of microarray experiments |
| Q33392732 | Statistical issues and analyses of in vivo and in vitro genomic data in order to identify clinically relevant profiles |
| Q37432339 | Statistical methods for gene set co-expression analysis |
| Q36117881 | Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program |
| Q36007347 | Stratification of acute myeloid leukemia based on gene expression profiles |
| Q37185376 | Stromal responses among common carcinomas correlated with clinicopathologic features |
| Q27644837 | Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK |
| Q35080295 | Study of suboptimum treatment response: lessons from breast cancer |
| Q61796263 | Subverted regulation of Nox1 NADPH oxidase-dependent oxidant generation by protein disulfide isomerase A1 in colon carcinoma cells with overactivated KRas |
| Q55609891 | Supervised wavelet method to predict patient survival from gene expression data. |
| Q37572162 | Survival analysis with high-dimensional covariates |
| Q28484571 | Survival prediction based on compound covariate under Cox proportional hazard models |
| Q42585784 | Survival prediction of stage I lung adenocarcinomas by expression of 10 genes |
| Q24802942 | Systematic analysis of T7 RNA polymerase based in vitro linear RNA amplification for use in microarray experiments |
| Q40248307 | Systems biology approaches to decoding the genome of liver cancer |
| Q37388535 | Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. |
| Q36765065 | T cell factor-4 functions as a co-activator to promote NF-κB-dependent MMP-15 expression in lung carcinoma cells |
| Q42366611 | TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection. |
| Q42128404 | TESTING SIGNIFICANCE OF FEATURES BY LASSOED PRINCIPAL COMPONENTS. |
| Q38748274 | TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation |
| Q37463901 | TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial-mesenchymal transition |
| Q38827071 | TRIM28 as an independent prognostic marker plays critical roles in glioma progression |
| Q41908005 | TSG: a new algorithm for binary and multi-class cancer classification and informative genes selection |
| Q33699499 | Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma. |
| Q36068326 | Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response. |
| Q41825773 | Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation. |
| Q34563757 | Technology Insight: tuning into the genetic orchestra using microarrays--limitations of DNA microarrays in clinical practice |
| Q47102597 | Temporal Prediction of Future State Occupation in a Multistate Model from High-Dimensional Baseline Covariates via Pseudo-Value Regression |
| Q56513677 | Text mining and network analysis of molecular interaction in non-small cell lung cancer by using natural language processing |
| Q34356297 | Tgf-beta signaling pathway in lung adenocarcinoma invasion. |
| Q38184819 | The 'omics' of adrenocortical tumours for personalized medicine. |
| Q36812744 | The Influence of the Global Gene Expression Shift on Downstream Analyses |
| Q92875491 | The Role of SATB1 in Tumour Progression and Metastasis |
| Q33320214 | The calcium-binding protein S100P in normal and malignant human tissues |
| Q51698466 | The classification of lung carcinoma: time to change the morphology-based approach? |
| Q47101861 | The clinical significance of CXCL5 in non-small cell lung cancer |
| Q90620485 | The clinical significance of collagen family gene expression in esophageal squamous cell carcinoma |
| Q37448891 | The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer |
| Q28383695 | The expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohorts |
| Q37400801 | The expression profile and clinic significance of the SIX family in non-small cell lung cancer |
| Q24802445 | The molecular basis of lung cancer: molecular abnormalities and therapeutic implications |
| Q35186535 | The morphological and molecular diagnosis of lung cancer |
| Q35479152 | The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling |
| Q33633330 | The receptor for advanced glycation end products (RAGE) and the lung |
| Q36538306 | The role of Sox genes in lung morphogenesis and cancer |
| Q37123982 | The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective |
| Q35667675 | The role of gene expression profiling in early-stage non-small cell lung cancer |
| Q30235880 | The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms. |
| Q51918208 | The signature from messenger RNA expression profiling can predict lymph node metastasis with high accuracy for non-small cell lung cancer. |
| Q37044593 | The state of molecular biomarkers for the early detection of lung cancer |
| Q34596148 | Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer |
| Q36121198 | Three-gene signature predicts disease progression of non-muscle invasive bladder cancer. |
| Q41125664 | Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis |
| Q34027928 | Top scoring pairs for feature selection in machine learning and applications to cancer outcome prediction. |
| Q31054943 | Topology-based cancer classification and related pathway mining using microarray data |
| Q47562619 | Toward the individualization of lung cancer therapy |
| Q38492817 | Towards mechanism classifiers: expression-anchored Gene Ontology signature predicts clinical outcome in lung adenocarcinoma patients |
| Q34768282 | Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy |
| Q33306709 | Transcriptional profiling of non-small cell lung cancer cells with activating EGFR somatic mutations |
| Q37448428 | Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis |
| Q24813887 | Transformation of expression intensities across generations of Affymetrix microarrays using sequence matching and regression modeling. |
| Q35199282 | Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines |
| Q36418751 | Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions |
| Q39011183 | Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. |
| Q21245745 | Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression |
| Q34288798 | Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis |
| Q38884723 | Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73. |
| Q36786055 | Unbiased Prediction and Feature Selection in High-Dimensional Survival Regression |
| Q37287067 | Update in lung cancer 2008 |
| Q37133934 | Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma |
| Q89966780 | Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma |
| Q34364597 | Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed. |
| Q91670728 | Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer |
| Q35143316 | Use of microarray technologies in toxicology research. |
| Q47971165 | Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma |
| Q30830295 | Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma |
| Q35018849 | Using prior knowledge and rule induction methods to discover molecular markers of prognosis in lung cancer. |
| Q35851755 | Using second harmonic generation to predict patient outcome in solid tumors. |
| Q47629982 | VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN. |
| Q33369633 | Very Important Pool (VIP) genes--an application for microarray-based molecular signatures |
| Q36972125 | Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. |
| Q36536565 | Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer |
| Q36755479 | YB-1, the E2F pathway, and regulation of tumor cell growth |
| Q28385778 | Yin Yang gene expression ratio signature for lung cancer prognosis |
| Q33685931 | ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism |
| Q80352865 | [Prognostic indicators in stage I non-small cell lung cancer] |
| Q38478183 | cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. |
| Q37080324 | iPcc: a novel feature extraction method for accurate disease class discovery and prediction |
| Q40074991 | mRMR-ABC: A Hybrid Gene Selection Algorithm for Cancer Classification Using Microarray Gene Expression Profiling |
| Q38742653 | miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3 |
| Q36209039 | miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro |
| Q90054171 | pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma |
| Q33606273 | permGPU: Using graphics processing units in RNA microarray association studies |
Search more.